Concepedia

Danilo S. Olivier

DS

8

Publications

171

Citations

8

H-Index

2016

Active since

Affiliations

Universidade Estadual Paulista (Unesp)(Current)

Forschungszentrum Jülich

Universidade Federal de Mato Grosso do Sul

Universidade Federal do Tocantins

Heinrich Heine University Düsseldorf

Danilo S. Olivier is an author at Universidade Estadual Paulista (Unesp) specializing in medicine, pharmacology, and cytoskeleton.

ORCID

Top concepts

Publications per year

2016–2022

8

Publications

8

The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CLpro In Vitro

Raphael J. Eberle, Danilo S. Olivier, Marcos Serrou do Amaral et al. · Viruses · 2021 · 36 citations · Full text

In vitro study of Hesperetin and Hesperidin as inhibitors of zika and chikungunya virus proteases

Raphael J. Eberle, Danilo S. Olivier, Carolina Colombelli Pacca et al. · PLoS ONE · 2021 · 34 citations · Full text

, , +14

Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition-

Mônika A. Coronado, Raphael J. Eberle, Nicole Bleffert et al. · Antiviral Research · 2018 · 27 citations · Full text

Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold

Raphael J. Eberle, Ian Gering, Markus Tusche et al. · Pharmaceuticals · 2022 · 17 citations · Full text

Interaction of Artepillin C with model membranes

Wallance Moreira Pazin, Danilo S. Olivier, Neus Vilanova et al. · European Biophysics Journal · 2016 · 16 citations · Full text

, , +4

Rows per page

1–5 of 8